Redpoint Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,542
Closed -$218K 594
2022
Q2
$218K Hold
5,542
0.03% 576
2022
Q1
$387K Hold
5,542
0.04% 496
2021
Q4
$431K Buy
5,542
+1,336
+32% +$118K 0.03% 486
2021
Q3
$401K Sell
4,206
-488
-10% -$51.5K 0.03% 502
2021
Q2
$584K Buy
4,694
+876
+23% +$105K 0.05% 415
2021
Q1
$503K Hold
3,818
0.04% 428
2020
Q4
$506K Buy
3,818
+726
+23% +$87.8K 0.05% 356
2020
Q3
$315K Buy
+3,092
New +$267K 0.03% 467

Other funds holding EXAS

Redpoint Investment Management's EXAS Position: Q3 2022 in Review

Redpoint Investment Management sold out of Exact Sciences (EXAS) in Q3 2022, closing a stake of 5,542 shares — an estimated $218K sold.

Redpoint Investment Management first reported a position in EXAS in Q3 2020 and held it in 8 quarters. The position peaked at $584K in Q2 2021. 479 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

  • Redpoint Investment Management reported no remaining Exact Sciences position as of Q3 2022 after selling out during the quarter.
  • Redpoint Investment Management sold 5,542 Exact Sciences shares in Q3 2022, an estimated $218K.
  • Redpoint Investment Management first reported a position in Exact Sciences in Q3 2020 and held it in 8 quarters.
  • Redpoint Investment Management's Exact Sciences position peaked at $584K in Q2 2021.
  • 479 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.